Hibiscus Blood Pressure Randomized Trial: What the Evidence Says

Quick Answer

Hibiscus Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• However, established risks associated with these medications such as metabolic disorders, hypotension, and hyperkalemia, necessitate the exploration of safer treatment options(Agarwal et al. [Kiani Maryam (2026); evidence level 2]
• After 90 days, HSE significantly reduced cholesterol (p<0.001), Low-Density Lipoprotein (LDL (p=0.010), and TG (p<0.001) levels more than control. [Kiani Maryam (2026); evidence level 2]
• Using a pre-characterized, standardized formulation, this study ensured reproducibility and generated evidence on how composite indices reflect short-term metabolic adaptation, thereby supporting their use in nutritional assessment and preventive health research. [Mendivil Edgar J. (2025); evidence level 2]
• Their selection was informed by prior observational and meta-analytic evidence linking these indices with incident atherosclerotic cardiovascular disease (ASCVD), CAD, and major adverse cardiovascular events, calculated as:whereandwere expressed in mmol/L for, andand glucose in mg/dL for thecalculation. [Mendivil Edgar J. (2025); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For hibiscus blood pressure randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Kiani Maryam (2026). Comparison of Hibiscus sabdariffa L. extract and hydrochlorothiazide as adjuncts to Valsartan in managing hypertension in type 2 diabetic nephropathy: A randomized clinical trial. DOI: 10.22038/ajp.2025.26575. PMCID: PMC13092151. PMID: 42011348. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ This work is licensed.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13092151/
• Mendivil Edgar J. (2025). Standardized Hibiscus&#8211;Inulin Shot Lowers Lipid&#8211;Glucose Indices in Adults with Overweight and Obesity: 8-Week Randomized Trial. DOI: 10.3390/nu17223556. PMCID: PMC12655153. PMID: 41305605. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12655153/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.